在患有左脑梗塞的患者中,对生物假体膜退化与明显的瘤进行重新TAVR

相关实验视频

Updated: May 11, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Weili Liu¹, Dacheng Li², Zhanjun Qu³

¹Interventional Operation Room Affiliated Hospital of Qingdao University Qingdao China.

Clinical case reports

|August 9, 2024

概括

重复透气管大动脉置换 (Redo-TAVR) 成功治疗了一名患有退行性生物假体大动脉的患者,该病因中风和脏问题而复杂. 这种方法为复杂的情况提供了可行的解决方案,需要重复的门干预.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学
心脏外科手术心脏外科手术

背景情况:

生物假体大动脉退化在术术大动脉置换 (SAVR) 和透气导管大动脉置换 (TAVR) 之后越来越令人担忧.
重制TAVR正在成为患有退化的生物假体门的患者的安全和有效选择,特别是那些具有高风险概况或复杂并发症的患者.
在患有脑梗塞和功能衰竭等先前存在的疾病的患者中,对Redo-TAVR的管理提出了独特的挑战.

研究的目的:

报告一个成功的Redo-TAVR的独特案例,该病例发生在一个患有生物假体退化症的患者身上,该病因左脑梗塞和功能不全而复杂.
突出在重复TAVR过程中使用的程序考虑和安全措施,在一个高风险的患者具有显著的并发症和前周围的瘤.

主要方法:

计算机断层扫描 (CT) 被用于确定Redo-TAVR的最佳定位和角度,因为之前的门更换中存在金属支架.
实施了脑保护装置,临时节奏和冠状动脉保护,以减轻与退化的门附近瘤潜在栓塞相关的风险.
重新TAVR手术进行时,要小心谨慎,以防止周围瘤的脱落.

主要成果:

在技术上,Redo-TAVR手术是成功的,没有与大脑保护或冠状动脉装置相关的直接并发症.
患者经历了显著改善的症状,包括减少胸部紧张和呼吸短促,后的程序.
术后恢复是无事件的,证明了在这个复杂的临床场景中Redo-TAVR的可行性.

结论:

在患有生物假体退行症的患者中,即使存在先前中风和功能不全等重大并发症,也可以安全有效地进行重新TAVR.
仔细的手术前规划和使用保护装置对于管理复杂解剖发现的患者的Redo-TAVR相关风险至关重要,包括周围瘤.
这一案例强调了Redo-TAVR作为一种有价值的治疗选择,在高风险患者群体中管理退化的生物假体门的不断扩大的作用.

关键词:

生物假肢退化症大脑梗塞脑梗塞这种新生体是瘤.重复透气管大动脉替换 (重复TAVR) 的方法

更多相关视频

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...